Skip to main content

4 Result(s)

within E. Voskaridou Remove this filter Oncology Remove this filter

and

  1. No Access

    Article

    The combination of intermediate doses of thalidomide with dexamethasone is an effective treatment for patients with refractory/relapsed multiple myeloma and normalizes abnormal bone remodeling, through the reduction of sRANKL/osteoprotegerin ratio

    The aim of this study was the evaluation of the effect of intermediate doses of thalidomide with dexamethasone (Thal/Dex) on disease course and bone disease in patients with refractory/relapsed myeloma who wer...

    E Terpos, D Mihou, R Szydlo, K Tsimirika, C Karkantaris, M Politou… in Leukemia (2005)

  2. No Access

    Article

    Inverse correlation of plasma leptin and soluble transferrin receptor levels in β-thalassemia patients

    The aim of the study was to investigate the association of leptin with hematological parameters in β-thalassemia patients in Greece. We measured plasma levels of soluble transferrin receptor (sTfR) and leptin...

    G. Dedoussis, M.-C. Kyrtsonis, N. Andrikopoulos, E. Voskaridou… in Annals of Hematology (2002)

  3. No Access

    Article

    Accelerated phase of chronic myeloid leukemia presenting as pericardial extramedullary hematopoiesis

    K. Konstantopoulos, A. Androulaki, E. Voskaridou, E. Archontis… in Annals of Hematology (1995)

  4. No Access

    Article

    Reticulocyte counting in thalassemic and other conditions with the R-1000 Sysmex analyzer

    Precise reticulocyte counts are difficult to obtain by the manual method when their percentage in the blood is low or normal. In these instances, rapid reticulocyte counting by flow cytometry appears to offer ...

    G. S. Paterakis, E. Voskaridou, A. Loutradi, J. Rombos… in Annals of Hematology (1991)